Trials / Completed
CompletedNCT07176819
Effectiveness of Gait Retraining in Female Runners With Patellofemoral Pain
Effectiveness of Gait Retraining in Female Runners With Patellofemoral Pain: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Beijing Sport University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Patellofemoral pain (PFP) is the most common running-related overuse injury, with prevalence up to 17% among runners. Increased patellofemoral joint stress (PFJS) is a major biomechanical contributor to PFP. Traditional strengthening exercises improve function but do not alter running biomechanics. Gait retraining, particularly cadence modification, has been proposed as a promising approach to reduce PFJS and alleviate symptoms. However, evidence from randomized controlled trials remains limited. This study investigates whether wearable device-assisted gait retraining reduces pain, improves function, and modifies running biomechanics in female runners with PFP compared to education alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Gait retraining | The intervention is a wearable device-assisted gait retraining program designed specifically for female runners with patellofemoral pain (PFP). Unlike conventional physiotherapy or exercise-based interventions, this program integrates real-time biofeedback through a commercially available smartwatch and its mobile application. Participants are instructed to increase their step rate by 10% above their preferred cadence. The smartwatch provides auditory metronome cues and real-time cadence feedback to ensure accurate step-rate modification. |
| BEHAVIORAL | Education | PFP education, load management strategies, symptom-based training modifications, and strengthening exercises. |
Timeline
- Start date
- 2023-02-21
- Primary completion
- 2023-12-23
- Completion
- 2023-12-23
- First posted
- 2025-09-16
- Last updated
- 2025-09-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07176819. Inclusion in this directory is not an endorsement.